BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT)

Last Price12.05

Change-0.13 (-1.03%)

NASDAQ · Last Trade: Dec 23rd, 1:50 PM EST

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?

Via The Motley Fool · December 22, 2025